摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-(2,6-dichlorophenyl)-8-methyl-2-{[4-(morpholin-4-yl)phenyl]amino}pyrido[2,3-d]pyrimidin-5(8H)-one | 1431324-74-1

中文名称
——
中文别名
——
英文名称
6-(2,6-dichlorophenyl)-8-methyl-2-{[4-(morpholin-4-yl)phenyl]amino}pyrido[2,3-d]pyrimidin-5(8H)-one
英文别名
6-(2,6-Dichlorophenyl)-8-methyl-2-(4-morpholin-4-ylanilino)pyrido[2,3-d]pyrimidin-5-one
6-(2,6-dichlorophenyl)-8-methyl-2-{[4-(morpholin-4-yl)phenyl]amino}pyrido[2,3-d]pyrimidin-5(8H)-one化学式
CAS
1431324-74-1
化学式
C24H21Cl2N5O2
mdl
——
分子量
482.369
InChiKey
WGZVPWWYLHUOTH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.8
  • 重原子数:
    33
  • 可旋转键数:
    4
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.21
  • 拓扑面积:
    70.6
  • 氢给体数:
    1
  • 氢受体数:
    7

文献信息

  • PYRIDOPYRIMIDINONE INHIBITORS OF KINASES
    申请人:AbbVie Inc.
    公开号:US20130102590A1
    公开(公告)日:2013-04-25
    The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts, wherein R 1 , R 2 , R 3 , R 4 , and B are defined in the description. The present invention relates also to compositions containing said compounds which are useful for inhibiting kinases such as wee-1 and methods of treating diseases such as cancer.
    本发明涉及式(I)的化合物或药用可接受的盐,其中R1、R2、R3、R4和B在描述中有定义。本发明还涉及含有上述化合物的组合物,用于抑制wee-1等激酶,并治疗癌症等疾病的方法。
  • US9181239B2
    申请人:——
    公开号:US9181239B2
    公开(公告)日:2015-11-10
  • [EN] PYRIDOPYRIMIDINONE INHIBITORS OF KINASES<br/>[FR] COMPOSÉS DE PYRIDOPYRIMIDINONE INHIBITEURS DE KINASES
    申请人:ABBVIE INC
    公开号:WO2013059485A1
    公开(公告)日:2013-04-25
    The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts, wherein R1, R2, R3, R4, and B are defined in the description. The present invention relates also to compositions containing said compounds which are useful for inhibiting kinases such as wee-1 and methods of treating diseases such as cancer.
查看更多